Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1673788 | 0.94 | TSHR (0.67) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL28278128 | 0.92 | TSHR (0.64) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL27843082 | 0.83 | TSHR (0.62) | TSHRTHRBALDH1A1 | |
| SCHEMBL13002391 | 0.81 | TSHR (0.64) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL27694725 | 0.81 | TSHR (0.55) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL28521766 | 0.80 | TSHR (0.69) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL4122484 | 0.80 | TSHR (0.69) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL20144633 | 0.80 | TSHR (0.58) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL21712455 | 0.80 | TSHR (0.53) | TSHRTHRBALDH1A1 | |
| SCHEMBL21119078 | 0.79 | TSHR (0.56) | TSHRTHRBALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1772470-B1 | METHOD FOR PRODUCING CARBOXYL GROUP-CONTAINING WATER-SOLUBLE POLYMER | SUMITOMO SEIKA CHEMICALS (JP) | 2012-09-26 | — | — | EP | disclosed |
| US-7521517-B2 | Method for producing carboxyl group-containing water-soluble polymer | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2009-04-21 | — | — | US | disclosed |
| US-20070225522-A1 | Method for Producing Carboxyl Group-Containing Water-Soluble Polymer | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1772470-A1 | METHOD FOR PRODUCING CARBOXYL GROUP-CONTAINING WATER-SOLUBLE POLYMER | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2007-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225522-A1 | Method for Producing Carboxyl Group-Containing Water-Soluble Polymer | MMAB, ASS1, MAT1A | TSHR 4559/4885THRB 3455/4885ALDH1A1 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.